• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,562.34 729.79
( 0.99%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0598066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
283.54
67559.44
EPS(TTM)
Face Value()
Div & Yield %
1.47
5
0.12
 

PDS consolidated net profit rises 21.71% in the March 2026 quarter
May 16,2026
Net profit of PDS rose 21.71% to Rs 49.05 crore in the quarter ended March 2026 as against Rs 40.30 crore during the previous quarter ended March 2025. Sales declined 0.19% to Rs 3519.03 crore in the quarter ended March 2026 as against Rs 3525.77 crore during the previous quarter ended March 2025.

For the full year,net profit declined 28.81% to Rs 111.69 crore in the year ended March 2026 as against Rs 156.89 crore during the previous year ended March 2025. Sales rose 4.23% to Rs 13110.08 crore in the year ended March 2026 as against Rs 12577.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3519.033525.77 0 13110.0812577.99 4
OPM %3.423.95 -2.923.63 -
PBDT114.58119.62 -4 336.35379.23 -11
PBT78.3184.10 -7 205.45268.49 -23
NP49.0540.30 22 111.69156.89 -29